Daftar Pustaka

1. Brun-Buisson C. The epidemiology of systemic infl ammatory response.

Intensive are Med. 2000;26 (Suppl 1):S64-74.
2. Burdette SD. Systemic infl ammatory response syndrome [Intenet]. [cited
2012 Aug 14]. Available from:
http://emedicine.medscape.com/article/168943-overview.
3. Cytokines in the systemic infl ammatory response syndrome: A review
[Internet]. [cited 2012 Aug 14]. Available from:
http://www.hsrproceedings.org/?pag=sezioni&id_sezione
=143&id_supersezione=13.
4. Laffey, J.G., Boylan, J.F., & Cheng, D.C. (2002). The systemic
inflamantory response to cardiac surgery: Implications for the
anesthesiologist. Anesthesiology, 97(1), 215-252.
5. Auer, J., Weber, T., Berent, R., Choi-Keung, Lamm, G., & Eber, B. (2005).
Risk Factors of postoperative atrial fibrillation after cardiac surgery.
Journal of Cardiac Surgery. 20, 425-431.
6. Mangano, D. (1985). Biventricular function after myocardial
revascularization in humans: Deterioration and recovery patterns during
the first 24 hours. Anesthesiology. 62(5), 571-577.
7. Hensley FA, Martin DE, Gravlen GP. A practical approach to cardiac
anesthesia. 3rd ed. Philadelphia: Lippincott Williams & Wilkins. 2003.
8. Djillali A, Sebille C, Charpentier PE, Bollaert B.,2002. Effect of Treatment
with Low dose of Hydrocortisone and Fludrocortisone on Mortality in
Patients with Septic Shock. JAMA.288:862-871
9. Djillali A dan Caillon DM, 2003. Corticosteroid in sepsis : from Bench to
bed side shock 20: 197-207
10. Goodman S and Charles LS.,2002. The international Sepsis forum,s
Controversies in Sepsis: Corticosteroids should be used to treat Septic
Shock.Crit care.6(5): 381-383
11. Jansen NJG, Van oeveren W, Gu YJ,et al., 1992. Endotoxin release and
tumor nekrosis factor formation during cardioplumonary bypass. Ann
thorac Surg 54 :744-748,1992
12. Cohn HL. Cardiac surgery in adult. 3rd ed. New York: Mc Graw Hill. 2008
13. Grave GP, Darvis RF, Utley JR. Cardiopulmonary bypass. 2 nd ed.
Maryland: William & Wilkins. 2000.
14. Hensley FA, martin DE, Gravlee GP. A practical approach to cardiac
anesthesia. 3rd ed. Philadelphia: Lippincott Williams & Wilkins. 2003.
15. Edmunds LH. Advances in heart-lung machine after john and mary
gibbon. Ann Thorac surg 2003; 76:2220-23.
16. Alsoufi B, Caldarone CA. Hypotermia, circulatory arrest and
cardiopulmonary bypass. 2009. Available from: URL:
http://www.emedicine.medscape.com.
17. Wesraby S. Organ dysfunction after cardiopulmonary bypass: a systemic
inflamatory reaction initiated by the extracorporeal circuit. Intensive Care
Med 1999;13:89-95.

45
18. Ilmakunnas M, Pesonen EJ, Ahonen J, Ramo J, Siitonen S. Activation of
neutrophils and monocytes by a leukocyte-depleting filter used throughout
cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005;129:851-9.
19. Asberg AE, Videm V. Neutrophil dysfunction after biomaterial contact in
an vitro model of cardiopulmonary bypass. Eur J Cardiothorac Surg 2006;
30:744-48.
20. Stites DP, Terr AT, Parslow TG. Medical immunology. 9th ed. Connectitut:
prentice-Hall International Inc. 1997;20-8.
21. Gilinov AM, Redmond JM, et al. Complement and neutrophil activation
during cardiopulmonary bypass: a study in the complement-deficient dog.
Ann thorac Surg 1994;57:342-52.
22. Kaplan JA et al. Cardiac Anesthesia. 7th edition,
23. Baratawijaya KG. Imunologi dasar. Edisi 6. Jakarta: balai Penerbit
FKUI.2004.
24. Frochlich D, Schwall B, et al. Effect of volatile anaesthetics on human
neutrophill oxidative response to the bacterial peptide. Br J Anaesth
1997;36:201-20.
25. Laffey JG, Boylan JF et al. The Systemic inflamatory response to cardiac
surgery: implication for the anesthesiologist. Anesthesiology
2002;97(1):215-52.
26. Miller BE. The Inflamatory response to cardiopulmonary bypass. J
Cardiothorac Vasc Anesthesia 1997;11:355-66.
27. Katzung G.B. Basic and Clinical Pharmacology. 9th ed. New York.
McGraw-Hill.2004.
28. Tjay TH dan Kirana Rahardja. Obat-obat Penting (Khasiat, Penggunaan
dan Efek Sampingnya). Jakarta : PT Elex Media Komputindo. 2007 : 404
–5
29. Papich, MG. Saunders Handbook of Veterinary Drugs Second edition. St
Louis Missouri. 2007: 278-89
30. P Hans, A. Vanthuyne, P. Y. Dewandre, J. F. Brichant and V.
BonhommeBlood glucose concentration profile after 10 mg
dexamethasone in non-diabetic and type 2 diabetic patients undergoing
abdominal surgery Oxford Journals Medicine BJA Volume 97, Issue
2.2006 Pp. 164-170.
31. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth
DE, Pacifico AD: Complement and the damaging effects of
cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983,
86:845-857

46